UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Post Holdings
POST
$3.57B
| $13.9M | ﹤0.01% |
133,249
+51,969
| +64% | +$5.41M |
|
1002
NIO
NIO
$11.9B
| $13.9M | ﹤0.01% |
3,332,639
-7,219,680
| -68% | -$34.2M |
|
1003
Commault Systems
CVLT
$5.61B
| $13.9M | ﹤0.01% |
113,956
+51,045
| +81% | +$5.48M |
|
1004
EXL Service
EXLS
$5.29B
| $13.8M | ﹤0.01% |
441,393
+251,586
| +133% | +$7.55M |
|
1005
Surgery Partners
SGRY
$2.03B
| $13.8M | ﹤0.01% |
580,316
+65,810
| +13% | +$1.69M |
|
|
ETRN
1006
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $13.7M | ﹤0.01% |
1,056,567
+520,987
| +97% | +$6.99M |
|
1007
Sun Communities
SUI
$14.7B
| $13.7M | ﹤0.01% |
113,957
-1,064,331
| -90% | -$126M |
|
1008
Cytokinetics
CYTK
$10.4B
| $13.7M | ﹤0.01% |
251,942
+134,020
| +114% | +$8.09M |
|
1009
AbCellera Biologics
ABCL
$2.12B
| $13.6M | ﹤0.01% |
+4,598,626
| New | +$17.4M |
|
1010
Chegg
CHGG
$102M
| $13.5M | ﹤0.01% |
4,284,098
+732,816
| +21% | +$3.64M |
|
1011
Ormat Technologies
ORA
$6.65B
| $13.5M | ﹤0.01% |
188,457
+122,168
| +184% | +$8.49M |
|
1012
Exponent
EXPO
$3.24B
| $13.5M | ﹤0.01% |
142,019
+80,920
| +132% | +$7.3M |
|
|
SMAR
1013
DELISTED
Smartsheet Inc.
SMAR
| $13.4M | ﹤0.01% |
304,952
+130,608
| +75% | +$5.21M |
|
1014
Olin
OLN
$2.12B
| $13.4M | ﹤0.01% |
284,136
+107,059
| +60% | +$5.73M |
|
1015
AutoNation
AN
$6.92B
| $13.4M | ﹤0.01% |
83,805
+16,091
| +24% | +$2.63M |
|
1016
MYR Group
MYRG
$5.25B
| $13.3M | ﹤0.01% |
98,155
+73,327
| +295% | +$11.5M |
|
|
RCM
1017
DELISTED
R1 RCM Inc. Common Stock
RCM
| $13.3M | ﹤0.01% |
1,059,167
+165,829
| +19% | +$2.06M |
|
1018
Omega Healthcare
OHI
$14.7B
| $13.3M | ﹤0.01% |
387,726
-970,399
| -71% | -$30.6M |
|
1019
Zurn Elkay Water Solutions
ZWS
$8.53B
| $13.3M | ﹤0.01% |
450,921
+229,750
| +104% | +$7.24M |
|
1020
Hanover Insurance
THG
$7.98B
| $13.2M | ﹤0.01% |
105,395
+32,898
| +45% | +$4.28M |
|
1021
Idacorp
IDA
$8.2B
| $13.2M | ﹤0.01% |
141,843
+34,221
| +32% | +$3.21M |
|
1022
UDR
UDR
$12.3B
| $13.2M | ﹤0.01% |
320,792
-2,469,942
| -89% | -$95.2M |
|
1023
Old National Bancorp
ONB
$10.2B
| $13.2M | ﹤0.01% |
767,159
+331,907
| +76% | +$5.52M |
|
1024
MasterBrand
MBC
$1.91B
| $13.2M | ﹤0.01% |
897,429
+308,606
| +52% | +$5.11M |
|
1025
Stantec
STN
$8.39B
| $13.1M | ﹤0.01% |
+157,252
| New | +$12.8M |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.